Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)
EPIGENT


Display

Display

  • Therapeutic indications
  • Epigent is indicated in adults and children. 


    Curative treatment for severe infections due to identified or suspected bacterial species, microbiologically sensitive to gentamicin. Under these conditions, Epigent can be used: in the following infections:

     Urinary tract infections, endocarditis, meningitis, osteo-articular infections, listeriosis, 

    Patients who may present with bacteremia associated or suspected to be associated with one of the infections mentioned above.


    In particular in risky situations (septic shock not microbiologically documented, late nosocomial injections, foreign body infections), In particular in subjects at risk (immunocompromised patients, newborns).


    Preventive treatment, prophylaxis of post-operative infections and prophylaxis during radiological procedures and interventional medicine, according to the recommendations for the proper use of antibiotics. Gentamicin is generally used as a curative treatment in combination with other antibiotics, in particular with beta-lactams. However, it can be prescribed as monotherapy in certain clinical situations, in particular in the treatment of urinary tract infections. Consideration should be given to official recommendations regarding the appropriate use of antibacterials.






WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1331288